Tweet
With decades of experience, PROSOL is a recognized leader in nucleotide development and ingredient standardization, delivering high-quality solutions for advanced nutraceutical formulations.
RiboMIX SC is nucleotide-based ingredient now available in the U.S. through Faravelli Inc., bringing proven scientific expertise to the local nutraceutical market.
A recent randomized controlled clinical trial showed promising results in supporting cognitive function in individuals with Mild Cognitive Impairment (MCI), an early stage of cognitive decline where daily activities remain largely unaffected.
The study involved 72 subjects (60–85 years).
After 6 months:
- Improved cognitive performance
- MoCA and MMSE returned to normal levels
- Improved mental well-being
These findings reinforce the potential of nucleotide-based ingredient as a valuable approach to early cognitive support and healthy aging, enabling the development of next-generation nutraceutical solutions.
Interested in understanding how RiboMIX SC can enhance your formulations?
Contact Faravelli Inc., PROSOL’s official distributor of RiboMIX SC in the U.S.












.jpg)















.jpg)





.jpg)





.jpg)



.jpg)

.jpg)






.jpg)



.jpg)

.jpg)
.jpg)


.jpg)























